These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32635420)

  • 1. Catching Common Cold Virus with a Net: Pyridostatin Forms Filaments in Tris Buffer That Trap Viruses-A Novel Antiviral Strategy?
    Real-Hohn A; Zhu R; Ganjian H; Ibrahim N; Hinterdorfer P; Kowalski H; Blaas D
    Viruses; 2020 Jul; 12(7):. PubMed ID: 32635420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhinovirus Inhibitors: Including a New Target, the Viral RNA.
    Real-Hohn A; Blaas D
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-quadruplex binder pyridostatin as an effective multi-target ZIKV inhibitor.
    Zou M; Li JY; Zhang MJ; Li JH; Huang JT; You PD; Liu SW; Zhou CQ
    Int J Biol Macromol; 2021 Nov; 190():178-188. PubMed ID: 34461156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C.
    Mello C; Aguayo E; Rodriguez M; Lee G; Jordan R; Cihlar T; Birkus G
    Antimicrob Agents Chemother; 2014; 58(3):1546-55. PubMed ID: 24366736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virucidal hand treatments for prevention of rhinovirus infection.
    Turner RB; Hendley JO
    J Antimicrob Chemother; 2005 Nov; 56(5):805-7. PubMed ID: 16159927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iota-Carrageenan is a potent inhibitor of rhinovirus infection.
    Grassauer A; Weinmuellner R; Meier C; Pretsch A; Prieschl-Grassauer E; Unger H
    Virol J; 2008 Sep; 5():107. PubMed ID: 18817582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-molecule-induced DNA damage identifies alternative DNA structures in human genes.
    Rodriguez R; Miller KM; Forment JV; Bradshaw CR; Nikan M; Britton S; Oelschlaegel T; Xhemalce B; Balasubramanian S; Jackson SP
    Nat Chem Biol; 2012 Feb; 8(3):301-10. PubMed ID: 22306580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of rhinovirus resistant to an antiviral chalcone.
    Ahmad AL; Dowsett AB; Tyrrell DA
    Antiviral Res; 1987 Aug; 8(1):27-39. PubMed ID: 2825590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based drug design of antirhinoviral compounds.
    Giranda VL
    Structure; 1994 Aug; 2(8):695-8. PubMed ID: 7994569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No G-Quadruplex Structures in the DNA of Parvovirus B19: Experimental Evidence versus Bioinformatic Predictions.
    Bua G; Tedesco D; Conti I; Reggiani A; Bartolini M; Gallinella G
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32854437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhinovirus inactivation by nasal tissues treated with virucide.
    Hayden GF; Gwaltney JM; Thacker DF; Hendley JO
    Antiviral Res; 1985 Apr; 5(2):103-9. PubMed ID: 2990332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synthetic STING agonist inhibits the replication of human parainfluenza virus 3 and rhinovirus 16 through distinct mechanisms.
    Zhu Q; Hu H; Liu H; Shen H; Yan Z; Gao L
    Antiviral Res; 2020 Nov; 183():104933. PubMed ID: 32949635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of the antirhinovirus flavanoid 4',6-dicyanoflavan.
    Conti C; Tomao P; Genovese D; Desideri N; Stein ML; Orsi N
    Antimicrob Agents Chemother; 1992 Jan; 36(1):95-9. PubMed ID: 1317152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in rhinovirus therapeutics.
    Charles CH; Yelmene M; Luo GX
    Curr Drug Targets Infect Disord; 2004 Dec; 4(4):331-7. PubMed ID: 15578974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on 44 081 R.P., a new antirhinovirus compound, in cell cultures and in volunteers.
    Zerial A; Werner GH; Phillpotts RJ; Willmann JS; Higgins PG; Tyrrell DA
    Antimicrob Agents Chemother; 1985 May; 27(5):846-50. PubMed ID: 2990329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-human rhinovirus 2 activity and mode of action of quercetin-7-glucoside from Lagerstroemia speciosa.
    Song JH; Park KS; Kwon DH; Choi HJ
    J Med Food; 2013 Apr; 16(4):274-9. PubMed ID: 23566054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histones and Neutrophil Extracellular Traps Enhance Tubular Necrosis and Remote Organ Injury in Ischemic AKI.
    Nakazawa D; Kumar SV; Marschner J; Desai J; Holderied A; Rath L; Kraft F; Lei Y; Fukasawa Y; Moeckel GW; Angelotti ML; Liapis H; Anders HJ
    J Am Soc Nephrol; 2017 Jun; 28(6):1753-1768. PubMed ID: 28073931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pentamer channel stiffening model for drug action on human rhinovirus HRV-1A.
    Vaidehi N; Goddard WA
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2466-71. PubMed ID: 9122218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular recognition of a carboxy pyridostatin toward G-quadruplex structures: Why does it prefer RNA?
    Rocca R; Talarico C; Moraca F; Costa G; Romeo I; Ortuso F; Alcaro S; Artese A
    Chem Biol Drug Des; 2017 Nov; 90(5):919-925. PubMed ID: 28459507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiviral activity of isoquinoline drugs for rhinoviruses in vitro and in vivo.
    Reed SE; Bynoe ML
    J Med Microbiol; 1970 May; 3(2):346-52. PubMed ID: 4318080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.